Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Core Growth Allocation ETF (AOR) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

iShares Core Growth Allocation ETFTrade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares Core Growth Allocation ETF vs Marsh & McLennan Companies, Inc. — how do they compare? iShares Core Growth Allocation ETF trades at $69.87, while Marsh & McLennan Companies, Inc. trades at $191.01 (market cap $91.27B). The key difference: Marsh & McLennan Companies, Inc. pays a 2.07% dividend while iShares Core Growth Allocation ETF pays none, and iShares Core Growth Allocation ETF is trading nearer its 52-week high, Marsh & McLennan Companies, Inc. nearer its low. Which is the better fit depends on your goals.

AORMRSH
52-Week High
$70.12$211.21
52-Week Low
$62.26$157.32
Market Cap
$91.27B
Sector
Financials
Enterprise Value
$111.95B
Dividend Yield
2.07%

Returns comparison

Trailing returns across standard periods

About iShares Core Growth Allocation ETF

The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.

Read more on AOR

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH